MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
about
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of GlioblastomaResistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like PropertiesA type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cellsFoxM1-mediated RFC5 expression promotes temozolomide resistance.
P2860
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
@en
type
label
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
@en
prefLabel
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
@en
P2093
P50
P1476
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
@en
P2093
Chris Jones
Geoffrey P Margison
Rachel White
P304
P356
10.1158/1535-7163.MCT-14-0810
P50
P577
2015-03-16T00:00:00Z